يعرض 1 - 20 نتائج من 132 نتيجة بحث عن '"Familial Mediterranean Fever (FMF)"', وقت الاستعلام: 0.90s تنقيح النتائج
  1. 1
    Academic Journal
  2. 2
    Academic Journal
  3. 3
  4. 4
    Academic Journal

    المؤلفون: Huseynova LS, Mammadova SN, Aliyeva KAA

    المصدر: Balkan Journal of Medical Genetics, Vol 24, Iss 2, Pp 33-38 (2022)

    وصف الملف: electronic resource

  5. 5
    Academic Journal
  6. 6
    Academic Journal

    المساهمون: Maladies rénales fréquentes et rares : des mécanismes moléculaires à la médecine personnalisée (CoRaKID), Institut National de la Santé et de la Recherche Médicale (INSERM)-Sorbonne Université (SU), CHU Tenon AP-HP, Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU), Hôpital Bicêtre AP-HP, Le Kremlin-Bicêtre, Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Sorbonne Université (SU), Centre Hospitalier Universitaire de Toulouse (CHU Toulouse), Centre Hospitalier Universitaire de Bordeaux (CHU Bordeaux), Hôpital Pellegrin, Centre Hospitalier Universitaire de Bordeaux (CHU Bordeaux)-Groupe hospitalier Pellegrin, Hôpital Necker - Enfants Malades AP-HP, Centre Hospitalier Universitaire Strasbourg (CHU Strasbourg), Les Hôpitaux Universitaires de Strasbourg (HUS), Hôpital Edouard Herriot CHU - HCL, Hospices Civils de Lyon (HCL), Service de Néphrologie, Dialyse, Transplantations CHU Limoges, CHU Limoges, CHU Montpellier = Montpellier University Hospital, Centre Hospitalier Régional Universitaire Montpellier (CHRU Montpellier), Centre de néphrologie et transplantation rénale Hôpital de la Conception - APHM, Assistance Publique - Hôpitaux de Marseille (APHM)-Hôpital de la Conception CHU - APHM (LA CONCEPTION), Hôpital Henri Mondor, Centre de Recherche en Transplantation et Immunologie - Center for Research in Transplantation and Translational Immunology (U1064 Inserm - CR2TI), Institut National de la Santé et de la Recherche Médicale (INSERM)-Nantes Université - UFR de Médecine et des Techniques Médicales (Nantes Univ - UFR MEDECINE), Nantes Université - pôle Santé, Nantes Université (Nantes Univ)-Nantes Université (Nantes Univ)-Nantes Université - pôle Santé, Nantes Université (Nantes Univ)-Nantes Université (Nantes Univ), Centre Hospitalier Universitaire de Nantes = Nantes University Hospital (CHU Nantes), Service de Néphrologie et Transplantation rénale CHRU-lille, Hôpital Claude Huriez Lille, Centre Hospitalier Régional Universitaire CHU Lille (CHRU Lille)-Centre Hospitalier Régional Universitaire CHU Lille (CHRU Lille), Hôpital Pasteur Nice (CHU), Hôpital Foch Suresnes, CHU Pitié-Salpêtrière AP-HP, CHU Amiens-Picardie, Service de Néphrologie-Dialyse-Transplantation CHU Amiens-Picardie, CHU Rouen, Normandie Université (NU), CHU Trousseau Tours, Centre Hospitalier Régional Universitaire de Tours (CHRU Tours), Hôpital Européen Georges Pompidou APHP (HEGP), Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpitaux Universitaires Paris Ouest - Hôpitaux Universitaires Île de France Ouest (HUPO), Service de Néphrologie CHRU Besançon, Centre Hospitalier Régional Universitaire de Besançon (CHRU Besançon), Service Néphrologie, Hémodialyses CHU Clermont-Ferrand, Pôle RHEUNNIRS CHU Clermont-Ferrand, CHU Gabriel Montpied Clermont-Ferrand, CHU Clermont-Ferrand-CHU Clermont-Ferrand-CHU Gabriel Montpied Clermont-Ferrand, CHU Clermont-Ferrand-CHU Clermont-Ferrand, Service de Néphrologie CHRU Nancy, Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy), Service de Néphrologie-Dialyse-Transplantation rénale CHU Caen, Université de Caen Normandie (UNICAEN), Normandie Université (NU)-Normandie Université (NU)-CHU Caen, Normandie Université (NU)-Tumorothèque de Caen Basse-Normandie (TCBN)-Tumorothèque de Caen Basse-Normandie (TCBN), Centre Hospitalier Universitaire d'Angers (CHU Angers), PRES Université Nantes Angers Le Mans (UNAM), Néphrologie CHU Bicêtre, Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpital Henri Mondor-Université Paris-Est Créteil Val-de-Marne - Paris 12 (UPEC UP12), Agence de la biomédecine Saint-Denis la Plaine, Département de pathologie Mondor, Service de pathologie CHU Necker, Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpital Necker - Enfants Malades AP-HP

    المصدر: ISSN: 0272-6386.

    Relation: info:eu-repo/semantics/altIdentifier/pmid/37741608; PUBMED: 37741608

  7. 7
    Academic Journal
  8. 8
    Academic Journal
  9. 9
    Academic Journal
  10. 10
    Academic Journal
  11. 11
    Academic Journal
  12. 12
    Academic Journal
  13. 13
    Academic Journal
  14. 14
    Academic Journal
  15. 15
    Academic Journal
  16. 16
    Academic Journal

    المؤلفون: P. Sotskiy O., П. Соцкий О.

    المصدر: Medical Genetics; Том 19, № 11 (2020); 4-12 ; Медицинская генетика; Том 19, № 11 (2020); 4-12 ; 2073-7998

    وصف الملف: application/pdf

    Relation: https://www.medgen-journal.ru/jour/article/view/1790/1423; Ben-Chetrit E., Levy M. Reproductive system in familial Mediterranean fever: an overview. Ann Rheum Dis. 2003; 62:916-919.; Mijatovic V., Hompes P.G., Wouters M.G. Familial Mediterranean fever and its implications for fertility and pregnancy. Eur J Obstet Gynecol Reprod Biol. 2003;108(2):171-176. doi:10.1016/s0301-2115(02)00417-7; Rabinovitch O., Zemer D., Kukia E. et al. Colchicine treatment in conception and pregnancy: two hundred thirty one pregnancies in patients with Familial Mediterranean Fever. Am J Reprod Immunol. 1992; 28:245-246.; Ehrenfeld M., Brzezinski A., Levy M., Eliakim M. Fertility and obstetric history in patients with familial Mediterranean fever on long-term colchicine therapy. Br J Obstet Gynaecol. 1987; 94(12):1186-1191. doi:10.1111/j.1471-0528.1987.tb02320.x; Zemer D., Pras M., Shemer Y. et al. Daily prophylactic colchicine in familial Mediterranean fever. In: Amyloid and amyloidosis. Proc 3rd International Symposium on Amyloidosis. Amsterdam-Oxford-Prinston: Exerpta Medica. 1980:580-583.; Michael O., Goldman R.D., Koren G. Safety of colchicine therapy during pregnancy. Can Fam Physician. 2003; 49:967-969.; Ben-Chetrit E., Levy M. Colchicine:1998 update. Semin Arthritis Rheum.1998;28(1):48-59. doi:10.1016/s0049-0172(98)80028-0; Amoura Z., Schermann J.M., Wechsler B. et al. Transplacental passage of colchicine in familial Mediterranean fever. J Rheumatol. 1994; 21(2):383.; Shoji R., Makino S. Preliminary notes on the teratogenic and embryocidal effects of colchicine on mouse embryos. Proc Jpn Acad. 1966; 42:822-827.; Berkenstadt M., Weisz B., Cuckle H. et al. Chromosomal abnormalities and birth defects among couples with colchicine treated familial Mediterranean fever. Am J Obstet Gynecol. 2005;193:1513-6. doi:10.1016/j.ajog.2005.03.043.; Ditkoff E.C., Sauer M.V. Successful pregnancy in a familial Mediterranean fever patient following assisted reproduction. J Assist Reprod Genet. 1996;13(8):684-685. doi:10.1007/BF02069651.; Ben-Chetrit E., Ben-Chetrit A., Berkun Y., Ben-Chetrit E. Pregnancy outcomes in women with familial Mediterranean fever receiving colchicine: is amniocentesis justified? Arthritis Care Res. 2010; 62:(2):143-148. doi:10.1002/acr.20061.; Tutuncu L., Atasoyu E.M., Evrenkaya R., Mungen E. Familial mediterranean fever-related nephrotic syndrome and successful full-term pregnancy. Arch Med Res. 2006; 37(1):178-180. doi:10.1016/j.arcmed.2005.04.013.; Akar Y., Yucel I., Akar M.E. et al. Long-term fluctuation of retinal sensitivity during pregnancy. Can J Ophthalmol. 2005; 40(4):487-491. doi:10.1016/S0008-4182(05)80011-0; Indraratna P., Virk S., Gurram D., Day R. Use of colchicine in pregnancy: A systematic review and meta-analysis. Rheumatology. (Oxford) 2018; 57(2):382-387. doi:10.1093/rheumatology/ kex353; Dotters-Katz S., Kuller J., Price T. The impact of familial Mediterranean fever on women’s health. Obstet Gynecol Surv. 2012; 67(6):357-64. doi:10.1097/OGX.0b013e318259ed3a; Yanmaz M.N., Özcan A.J., Savan K. The impact of familial Mediterranean fever on reproductive system. Clin Rheumatol. 2014; 33(10):1385-1388. doi:10.1007/s10067-014-2709-9; Sarı İ., Birlik M., Kasifoğlu T. Familial Mediterranean fever: An updated review. Eur J Rheumatol. 2014;1(1):21-33. doi:10.5152/eurjrheum.2014.006; Ozdogan H., Ugurlu S. Familial Mediterranean Fever. Presse Med. 2019;48(1):61-76. doi:10.1016/j.lpm.2018.08.014.; Update of the Joint European League Against Rheumatism and European Renal Association - European Dialysis and Transplant Association (EULAR/ER-EDTA) recommendations for the management of lupus nephritis. Annals of the Rheumatic Diseases 2020;79(6):713-723. doi:10.1136/annrheumdis-2020-216924; Yasar O., Iskender C., Kaymak O. et al. Retrospective evaluation of pregnancy outcomes in women with familial Mediterranean fever. J Matern Fetal Neonatal Med. 2014;27(7):733-736. doi:10.3109/14767058.2013.837446; Nabil H., Zayed A., State O., Badawy A. Pregnancy outcome in women with familial Mediterranean fever. J Obstet Gynaecol. 2012;32(8):756-759. doi:10.3109/01443615.2012. 698667; Fortunato S.J., Menon R., Lombardi S.J. Support for an infectioninduced apoptotic pathway in human fetal membranes. Am J Obstet Gynecol. 2001;184:1392-1397. doi:10.1067/mob.2001.115434; Romero R., Friel L.A., Velez Edwards D.R., et al. A genetic association study of maternal and fetal candidate genes that predispose to preterm prelabor rupture of membranes (PROM). Am J Obstet Gynecol. 2010;203:361. doi:https://doi.org/10.1016/j.ajog.2010.05.026; Ofir D., Levy A., Wiznitzer A. et al. Familial Mediterranean fever during pregnancy: an independent risk factor for preterm delivery. Eur J Obstet Gynecol Reprod Biol. 2008; 141:115-118. doi:10.1016/j.ejogrb.2008.07.025; Shepard T.H. Catalog of teratogenic agents, 6th ed. Baltimore, MD: Johns Hopkins University Press; 1989:164-166.; Ferreira N.R., Buoniconti A. Trisomy after colchicine therapy. Lancet. 1968;2:1304.; Ben-Chetrit E., Berkun Y., Ben-Chetrit E., Ben-Chetrit A. The outcome of pregnancy in the wives of men with familial mediterranean fever treated with colchicine. Semin Arthritis Rheum. 2004;34(2):549-552. doi:10.1016/j.semarthrit.2004.07.004; Wang X., Chen C., Wang L. et al. Conception, early pregnancy loss, and time to clinical pregnancy: a populationbased prospective study. Fertil Steril 2003;79:577-584. doi:10.1016/s0015-0282(02)04694-0; Ben-Chetrit E., Levy M. Colchicine prophylaxis in familial Mediterranean fever: reappraisal after 15 years. Semin Arthritis Rheum 1991; 20:241-246. doi:10.1016/0049-0172(91)90019-v; Cestari A.N., Botelho Vieira Filho J.P., Yonenaga Y. et al. A case of human reproductive abnormalities possibly induced by colchicine treatment. Rev Bras Biol. 1965;25:253.; Cohen M.M., Levy M., Eliakim M.A. Cytogenic evaluation of long-term colchicine therapy in the treatment of Familial Mediterranean fever (FMF). Am J Med Sci. 1977;274(2):147-152. doi:10.1097/ 00000441-197709000-00005; Diav-Citrin O., Shechtman S., Schwartz V. et al. Pregnancy outcome after in utero exposure to colchicine. Am J Obstet Gynecol. 2010;203:144. doi:10.1016/j.ajog.2010.02.063; Ben-Chetrit E., Scherrmann J.M., Levy M. Colchicine in breast milk of patients with familial Mediterranean fever. Arthritis Rheum. 1996;39:1213-1217. doi:10.1002/art.1780390721; Milunsky J.M. Breast-feeding during colchicine therapy for familial Mediterranean fever. J Pediatr. 1991;119:164. doi:10.1016/s0022-3476(05)81070-4; Mordel N., Birkenfeld A., Rubinger D. et al. Successful full-term pregnancy in familial Mediterranean fever complicated with amyloidosis: case report and review of the literature. Fetal Diagn Ther. 1993;8:129-134. doi:10.1159/000263761; Shimoni Y., Shalev E. Pregnancy and complicated familial Mediterranean fever. Int J Gynaecol Obstet. 1990;33(2):165-169. doi:10.1016/0020-7292(90)90591-8.; Yazicioğlu A., Turgal M., Senem O. et al. Pregnancy Outcome in Women with familial Mediterranean fever: A Retrospective Analysis of 50 Cases with a 10-Year Experience. Arch Rheumatol. 2014;29(2):94-98. doi:10.5606/ArchRheumatol.2014.3707; Ozen S., Demirkaya E., Erer B. et al. EULAR recommendations for the management of familial Mediterranean fever. Annals of the Rheumatic Diseases 2016;75:644-651. doi:10.1136/annrheumdis- 2015-208690; İlgen U., Küçükşahin O. Anakinra use during pregnancy: Report of a case with Familial Mediterranean Fever and infertility. Eur J Rheumatol 2017;4(1):66-67. doi:10.5152/ eurjrheum.2017.16075; Lidar M., Yonath H., Shechter N. et al. Incomplete response to colchicine in M694V homozygote FMF patients. Autoimmun Rev 2012;12(1):72-76. doi:10.1016/j.autrev.2012.07. 025.; Sönmez H.E., Batu E.D., Özen S. Familial Mediterranean fever: current perspectives. J Inflamm Res 2016;9:13-20. doi:10.2147/JIR.S91352; Livneh A., Cabili S., Zemer D. et al. Effect of pregnancy on renal function in amyloidosis of familial Mediterranean fever. J. Rheumatol.1993;20:1519-1523.; Hentgen V., Grateau G., Kone-Paut I. et al. EULAR recommendations for the practical maganement of Familial Mediterranean Fever. Seminars in arthritis and rheumatism. Elsevier 2013;387-391. doi:10.1016/j.semarthrit.2013.04.011; Yilmaz N.K., Kara M., Kaba M. et al. Effect of Familial Mediterranean Fever on IVF outcome: A Retrospective Case Series. Acta Clin Croat 2016; 55:254-258. doi:10.20471/acc.2016.55.02.11.; Ozdogan H., Ugurlu S. Canakinumab for the treatment of familial Mediterranean fever. Expert Rev ClinImmunol. 2017;13(5):393-404. doi:10.1080/1744666X.2017.1313116; Heng Y.J., Liong S., Permezel M. et al. The interplay of interleukin-1 system in pregnancy and labor. Reprod Sci. 2011;21:122-130. doi:10.1177/1933719113492204; Berger C.T., Recher M., Steiner U., Hauser T.M. A patient’s wish: anakinra in pregnancy. Ann Rheum Dis. 2009;68(11):1794-1795. doi:10.1136/ard.2008.105833.; Chang Z., Spong C.Y., Jesus A.A. et al. Anakinra use during pregnancy in patients with cryopyrin-associated periodic syndromes (CAPS). Arthritis Rheumatol. 2014; 66:3227-3232. doi:10.1002/ art.38811; Fischer-Betz R., Specker C., Schneider M. Successfull outcome of two pregnancies in patients with adult onset Still’s disease treated with IL-1 receptor antagonist (anakinra) Clin Exp Rheumatol. 2011; 29:1021-1023.; Lachman H.J., Ozdogan H., Simon A. et al. Anti IL-1 therapies and pregnancy outcome. Pediatr Rheumatol Online J. 11(Suppl 1):A269. doi:10.1186/1546-0096-11-S1-A269; Ozdogan H., Ugurlu S., Ergezen B. The pregnancy outcomes in patients who are exposed to IL-1 blockade with anakinra. Ann Rheum Dis. 2015;74:400-401.; Youngstein T., Hoffman P., Gul A. et al. International multi-centre study of pregnancy outcomes with interleukin-1 inhibitors. Rheumatology. 2017;56:2102-2108. doi:10.1093/rheumatology/ kex305; https://www.medgen-journal.ru/jour/article/view/1790

  17. 17
    Academic Journal
  18. 18
    Academic Journal
  19. 19
  20. 20
    Academic Journal